• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Cumulative percentage of federal employees with a clearance greater than a Level 1 clearance

Cumulative FY 2011 Target: 100% of 239 employees by 3/30/2011

Dictionary: RCRM is responsible for completing all background investigations and processing security clearances for NCTR federal employees.

Maintaining current background checks and security clearances on all NCTR federal employees will help keep the NCTR workforce safer (1).

Fiscal Year - 2011

Skip graphic and jump to text data

Cumulative FY 2011 Target: 100% of 239 employees by 3/30/2011

TimeTargetCumulative Percent
Oct 2010N/A77
Nov 2010N/A99
Dec 2010N/A100
Jan 2011N/A100
Feb 2011N/A100

FY 2011 YTD: 100%

Footnotes

  • (1) As all applicable NCTR federal employees have received security clearances, this measure will be retired beginning in March 2011.

Cumulative number of federal employees who received a clearance greater than a Level 1 clearance (2)

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeCumulative Monthly TargetCumulative Number
Oct 2010N/A185
Nov 2010N/A237
Dec 2010N/A239
Jan 2011N/A239
Feb 2011N/A239

FY 2011 YTD: 239

Footnotes

  • (2) This target represents a goal of 15 employees who clearances were completed each month. This will help RCRM gauge performance on a monthly basis to ensure 100% of NCTR federal employees are appropriately cleared by the end of FY 2010.

Number of federal employees at NCTR at the end of the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetTotal Number
Oct 2010N/A239
Nov 2010N/A239
Dec 2010N/A239
Jan 2011N/A239
Feb 2011N/A239

FY 2011 YTD: 239

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.